Literature DB >> 2710529

Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration.

J S Sunness1, R W Massof, M A Johnson, N M Bressler, S B Bressler, S L Fine.   

Abstract

Visual function testing was performed on one eye with drusen from each of 18 elderly patients in 1984. Eleven patients had advanced age-related macular degeneration (AMD) in the fellow eye, and seven had only bilateral drusen. These patients were all followed prospectively (median, 45 months), at which time one eye had a new vessel membrane, three eyes had pigment epithelial detachments, and one eye had geographic atrophy. Only two of these five eyes had AMD-related visual loss in the fellow eye in 1984. The degree of loss of foveal dark-adapted sensitivity in 1984 predicted which patients developed advanced AMD with 100% sensitivity and 92% specificity. The presence of high-risk drusen characteristics in 1984 predicted the development of advanced AMD with 100% sensitivity but only 55% specificity. For this small group of patients, foveal dark-adapted sensitivity loss was an excellent predictor of the subsequent development of advanced AMD in eyes with drusen. A prospective study of a large group of patients with drusen is being undertaken to validate this finding.

Entities:  

Mesh:

Year:  1989        PMID: 2710529     DOI: 10.1016/s0161-6420(89)32883-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  22 in total

Review 1.  Bruch's membrane change with age.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

2.  The local cone and rod system function in early age-related macular degeneration.

Authors:  Changzheng Chen; Lezheng Wu; Dezheng Wu; Shizhou Huang; Feng Wen; Guangwei Luo; Shixian Long
Journal:  Doc Ophthalmol       Date:  2004-07       Impact factor: 2.379

3.  Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy.

Authors:  Mark E Clark; Gerald McGwin; David Neely; Richard Feist; John O Mason; Martin Thomley; Milton F White; Bunyamin Ozaydin; Christopher A Girkin; Cynthia Owsley
Journal:  Br J Ophthalmol       Date:  2011-02-02       Impact factor: 4.638

4.  En face optical coherence tomography of transient light response at photoreceptor outer segments in living frog eyecup.

Authors:  Benquan Wang; Rongwen Lu; Qiuxiang Zhang; Yuqiang Jiang; Xincheng Yao
Journal:  Opt Lett       Date:  2013-11-15       Impact factor: 3.776

Review 5.  Functional optical coherence tomography of retinal photoreceptors.

Authors:  Xincheng Yao; Taeyoon Son; Tae-Hoon Kim; Yiming Lu
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-27

6.  Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease.

Authors:  A Remky; A E Elsner
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

7.  Impact of motion-associated noise on intrinsic optical signal imaging in humans with optical coherence tomography.

Authors:  Michel M Teussink; Barry Cense; Mark J J P van Grinsven; B Jeroen Klevering; Carel B Hoyng; Thomas Theelen
Journal:  Biomed Opt Express       Date:  2015-04-09       Impact factor: 3.732

8.  Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.

Authors:  Gui-Shuang Ying; Maureen G Maguire; Chengcheng Liu; Andrew N Antoszyk
Journal:  Ophthalmology       Date:  2008-07-31       Impact factor: 12.079

9.  In vivo confocal intrinsic optical signal identification of localized retinal dysfunction.

Authors:  Qiu-Xiang Zhang; Rong-Wen Lu; Christine A Curcio; Xin-Cheng Yao
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

10.  Colour contrast sensitivity in patients with soft drusen, an early stage of ARM.

Authors:  C Frennesson; U L Nilsson; S E Nilsson
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.